Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![teambullish95 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1651073071.png) Jones [@teambullish95](/creator/twitter/teambullish95) on x XXX followers
Created: 2025-06-30 16:33:19 UTC

$ARGX Argenx announces plan to advance clinical development of ARGX-119 

Argenx announced its plan to advance the clinical development of ARGX-119, an agonist antibody to muscle-specific kinase, to a registrational study in patients with congenital myasthenic syndromes.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1939723937132253355/c:line.svg)

**Related Topics**
[$argx](/topic/$argx)

[Post Link](https://x.com/teambullish95/status/1939723937132253355)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

teambullish95 Avatar Jones @teambullish95 on x XXX followers Created: 2025-06-30 16:33:19 UTC

$ARGX Argenx announces plan to advance clinical development of ARGX-119

Argenx announced its plan to advance the clinical development of ARGX-119, an agonist antibody to muscle-specific kinase, to a registrational study in patients with congenital myasthenic syndromes.

XXX engagements

Engagements Line Chart

Related Topics $argx

Post Link

post/tweet::1939723937132253355
/post/tweet::1939723937132253355